PTPRC and neoplasm: Tumor abundance of TS representing immune cells and the gene (PTPRC) encoding the common leukocyte antigen, CD45, were associated with improved prognosis in HPV-infected HNSCC patients compared to uninfected patients and positively correlated with HPV viral loads, suggesting HPV infection may enhance anti-tumor immunity in HNSCC patients.